טוען...
A282 DOES SERUM ADALIMUMAB LEVEL CORRELATE WITH DISEASE SEVERITY IN PATIENTS WITH CROHN’S DISEASE?
AIMS: Tests measuring serum adalimumab levels are not widely available. We aim to evaluate whether serum adalimumab levels correlate with disease severity in patients with Crohn’s disease. Additionally, as the test is expensive, we aim to see if clinical and biochemical markers can be used as a surr...
שמור ב:
| הוצא לאור ב: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507945/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.283 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|